These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 54813)

  • 1. Letter: Acute myelocytic leukeaemia and leukaemia-associated antigen in sisters.
    Parker JE
    Lancet; 1975 Dec; 2(7948):1301. PubMed ID: 54813
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myelocytic leukaemia and leukaemia-associated antigens in sisters.
    Pendergrass TW; Mann DL; Stoller RG; Halterman RH; Fraumeni JF
    Lancet; 1975 Sep; 2(7932):429-31. PubMed ID: 51238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemia in identical twins: search for viral and leukemia-associated antigens.
    Levine PH; Herberman RB; Rosenberg EB; McClure PD; Roland A; Pienta RJ; Ting RC
    J Natl Cancer Inst; 1972 Oct; 49(4):943-52. PubMed ID: 4343478
    [No Abstract]   [Full Text] [Related]  

  • 4. Human leukaemia-associated antigens expressed by acute myelocytic leukaemia cells and their detection by heterologous antisera.
    Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):311-20. PubMed ID: 89982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Immunotherapy for acute myeloid leukaemia.
    Lancet; 1974 May; 1(7862):846-7. PubMed ID: 4132795
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukaemia-associated antigen in serum of patients with acute lymphoblastic leukaemia.
    Chechik BE; Gelfand EW
    Lancet; 1976 Jan; 1(7952):166-8. PubMed ID: 54682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific cross-reacting antigen as a marker of myelocytic leukemias in individual stages of myelocytic cell differentiation.
    Harłozińska A; Noworolska A; Richter R
    Haematol Blood Transfus; 1985; 29():194-6. PubMed ID: 3861480
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukaemia-associated antigens and related antibodies in family of lymphoma patient.
    Bertoglio J; Doré JF; Squillet G
    Lancet; 1976 Jul; 2(7978):204-5. PubMed ID: 73829
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization of a membrane antigen which exhibits specificity for cells of patients with acute myelogenous leukaemia.
    Shipman R; Malcolm A; Levy JG
    Br J Cancer; 1983 Jun; 47(6):849-52. PubMed ID: 6190494
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukemic myeloblasts expressing lymphoid markers.
    Reizenstein P; Beksac M; Biberfeld P; Christensson B; Lagerlöf B; Laurén L; Ost A; Porwit A
    Acta Haematol; 1985; 74(3):148-50. PubMed ID: 2937254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
    Ratei R; Sperling C; Ludwig WD
    Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
    Cocks P; Powles RL; Chapuis B; Alexander P
    Br J Cancer; 1977 Mar; 35(3):273-9. PubMed ID: 139910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
    Guinn BA; Bland EA; Lodi U; Liggins AP; Tobal K; Petters S; Wells JW; Banham AH; Mufti GJ
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1293-304. PubMed ID: 16112646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
    Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
    Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivity of antibody in acute myeloid leukaemia with proliferation-associated nuclear antigen(s).
    Russell AR; Pope JH
    Clin Exp Immunol; 1976 Jan; 23(1):83-90. PubMed ID: 1063068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of cross-lineage antigenic expression in acute myeloid leukaemia cells of elderly patients.
    Marotta G; Sorio R; Gattei V; Bullian PL; De Rosa L; Mancardi S; Attadia V; Carbone A; Monfardini S; Zagonel V
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():20. PubMed ID: 2627601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.